Back to Search
HERMAN HURWITZ, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1376751776Individual
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
MD007085E(PA)
Research & Publications (20)
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
PMID 15908660·J Clin Oncol·2005
3-trial
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
PMID 18805651·Int J Radiat Oncol Biol Phys·2009
8-other
Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression.
PMID 19652084·Hypertension·2009
7-preclinical
Phase I trial of pazopanib in patients with advanced cancer.
PMID 19509175·Clin Cancer Res·2009
3-trial
Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.
PMID 18685900·J Gastrointest Surg·2009
4-observational
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials.
PMID 19064978·J Clin Oncol·2009
2-rct
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
PMID 19144677·Oncologist·2009
3-trial
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
PMID 18182660·J Clin Oncol·2008
4-observational
Physicians pay attention: you aren't testing your patients adequately for kidney disease!
PMID 18449365·Medscape J Med·2008
8-other
Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk.
PMID 18852492·Oncology·2008
8-other
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer.
PMID 18776057·Oncologist·2008
3-trial
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.
PMID 18193223·Cancer Immunol Immunother·2008
8-other
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
PMID 17881149·Int J Radiat Oncol Biol Phys·2008
3-trial
Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
PMID 18155574·J Am Coll Surg·2008
4-observational
Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?
PMID 19385771·J Empir Res Hum Res Ethics·2008
8-other
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer.
PMID 18829508·Clin Cancer Res·2008
3-trial
Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy.
PMID 17689032·Int J Radiat Oncol Biol Phys·2007
4-observational
Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.
PMID 17889266·Int J Radiat Oncol Biol Phys·2007
4-observational
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
PMID 17947727·J Clin Oncol·2007
3-trial
Readers respond to "it is time to extend the laboratory critical (panic) value system to include vital values".
PMID 17955067·MedGenMed·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 900 BUSINESS CENTER DR
HORSHAM, PA 19044 - Phone
- (215) 442-7673
Quick Facts
- NPI
- 1376751776
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile